| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Flexion Therapeutics Inc | Chief Financial Officer | Common Stock | 220,719 | $1,876,112 | $8.50 | 10 May 2021 | Direct |
| Seres Therapeutics, Inc. | Chief Financial Officer | Common Stock | 182,442 | $197,037 | $1.08 | 16 Feb 2024 | Direct |
| iBio, Inc. | Director | Common Stock | 18,382 | $49,999 | $2.72 | 10 Jan 2025 | Direct |
| Seres Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 31,875 | $43,031 | $1.35 | 15 Feb 2024 | Direct |
| KINETA, INC./DE | Director | Common Stock | 0 | $0 | $0.3300 | 30 Jun 2025 | Direct |
| Seres Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 287,905 | 14 Feb 2024 | Direct | ||
| iBio, Inc. | Director | Stock Option (right to buy) | 13,500 | 20 Nov 2025 | Direct | ||
| F-star Therapeutics, Inc. | Director | Common Stock | 0 | $7.12 | 08 Mar 2023 | Direct | |
| F-star Therapeutics, Inc. | Director | Warrant (right to buy) | 0 | 20 Nov 2020 | Direct | ||
| KINETA, INC./DE | Director | Stock Option (Right to Buy) | 0 | 30 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IBIO | iBio, Inc. | 20 Nov 2025 | 1 | $0 | 4 | Director | 24 Nov 2025, 16:05 |
| KANT | KINETA, INC./DE | 30 Jun 2025 | 3 | $0 | 4 | Director | 02 Jul 2025, 16:21 |
| KANT | KINETA, INC./DE | 23 Jun 2025 | 4 | +$6,414 | 4 | Director | 25 Jun 2025, 21:49 |
| IBIO | iBio, Inc. | 10 Jan 2025 | 1 | +$49,999 | 4 | Director | 13 Jan 2025, 16:32 |
| IBIO | iBio, Inc. | 21 Nov 2024 | 1 | $0 | 4 | Director | 25 Nov 2024, 16:31 |
| IBIO | iBio, Inc. | 21 Nov 2024 | 0 | $0 | 3 | Director | 25 Nov 2024, 16:30 |
| KA | KINETA, INC./DE | 04 Sep 2024 | 1 | $0 | 4 | Director | 05 Sep 2024, 16:18 |
| MCRB | Seres Therapeutics, Inc. | 14 Feb 2024 | 6 | -$4,254 | 4 | Chief Financial Officer | 16 Feb 2024, 21:13 |
| MCRB | Seres Therapeutics, Inc. | 27 Oct 2023 | 4 | -$5,489 | 4 | Chief Financial Officer | 31 Oct 2023, 21:39 |
| MCRB | Seres Therapeutics, Inc. | 27 Apr 2023 | 1 | $0 | 4 | Chief Financial Officer | 01 May 2023, 16:43 |
| KA | KINETA, INC./DE | 12 Apr 2023 | 2 | $0 | 4 | Director | 14 Apr 2023, 16:06 |
| MCRB | Seres Therapeutics, Inc. | 03 Feb 2023 | 2 | $0 | 4 | Chief Financial Officer | 07 Feb 2023, 16:44 |
| MCRB | Seres Therapeutics, Inc. | 05 Jul 2022 | 1 | +$200,000 | 4 | Chief Financial Officer | 06 Jul 2022, 19:23 |
| FSTX | F-star Therapeutics, Inc. | 17 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 17:06 |
| MCRB | Seres Therapeutics, Inc. | 15 Jun 2022 | 3 | $0 | 4 | Chief Financial Officer | 31 Oct 2022, 18:05 |
| MCRB | Seres Therapeutics, Inc. | 04 Feb 2022 | 1 | $0 | 4 | Executive Vice President, Chief Financial Officer and Head of Business Development | 08 Feb 2022, 20:30 |
| FSTX | F-star Therapeutics, Inc. | 04 Jun 2021 | 1 | $0 | 4 | Director | 07 Jun 2021, 16:03 |
| KA | YUMANITY THERAPEUTICS, INC. | 02 Jun 2021 | 1 | $0 | 4 | Director | 04 Jun 2021, 16:05 |
| MCRB | Seres Therapeutics, Inc. | 01 Jun 2021 | 2 | $0 | 4 | Chief Financial Officer | 01 Jun 2021, 21:25 |
| MCRB | Seres Therapeutics, Inc. | 01 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 01 Jun 2021, 21:14 |
| FLXN | Flexion Therapeutics Inc | 10 May 2021 | 1 | -$16,116 | 4 | Chief Financial Officer | 12 May 2021, 17:06 |
| FSTX | F-star Therapeutics, Inc. | 20 Nov 2020 | 10 | -$59,708 | 4 | Director | 09 Mar 2023, 08:10 |